Pharmaceutical composition for preventing and treating dry eye diseases, containing imatinib as active ingredient
US10231971B2 · kind B2 · utility
0Cited by
0References
4Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jun 22, 2016 |
| Grant date | Mar 19, 2019 |
| Priority date | — |
| Expiry date | Jun 22, 2036 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P27/04
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to a composition for preventing or treating dry eye syndrome or eye diseases caused by dry dyes, containing imatinib as an active ingredient and, more specifically, to an eye bath lotion for preventing or treating dry eye syndrome or eye diseases associated with dry eye syndrome, containing imatinib an active ingredient. Imatinib of the present invention effectively protects the corneal epithelia and inhibits the degeneration thereof, thereby being usable for a use of alleviating or treating dry eye syndrome or eye diseases associated with dry eye syndrome.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.